Ítem
Solo Metadatos
5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction
dc.creator | García?Perdomo, Herney A | spa |
dc.creator | Lopez, Hugo E | spa |
dc.creator | Tacklind, James | spa |
dc.date.accessioned | 2020-05-26T00:04:38Z | |
dc.date.available | 2020-05-26T00:04:38Z | |
dc.date.created | 2015 | spa |
dc.description.abstract | This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of 5-alpha-reductase inhibitors (5ARIs) for treating lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction (BPO). © 2015 The Cochrane Collaboration. | eng |
dc.format.mimetype | application/pdf | |
dc.identifier.doi | https://doi.org/10.1002/14651858.CD011928 | |
dc.identifier.issn | 1469493X | |
dc.identifier.uri | https://repository.urosario.edu.co/handle/10336/23701 | |
dc.language.iso | eng | spa |
dc.publisher | John Wiley and Sons Ltd | spa |
dc.relation.citationIssue | No. 11 | |
dc.relation.citationTitle | Cochrane Database of Systematic Reviews | |
dc.relation.citationVolume | Vol. 2015 | |
dc.relation.ispartof | Cochrane Database of Systematic Reviews, ISSN:1469493X, Vol.2015, No.11 (2015) | spa |
dc.relation.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041748285&doi=10.1002%2f14651858.CD011928&partnerID=40&md5=c8b19146507d0ecf36cf8c96f7f941e1 | spa |
dc.rights.accesRights | info:eu-repo/semantics/openAccess | |
dc.rights.acceso | Abierto (Texto Completo) | spa |
dc.source.instname | instname:Universidad del Rosario | spa |
dc.source.reponame | reponame:Repositorio Institucional EdocUR | spa |
dc.subject.keyword | Dutasteride | spa |
dc.subject.keyword | Finasteride | spa |
dc.subject.keyword | Steroid 5alpha reductase inhibitor | spa |
dc.subject.keyword | Article | spa |
dc.subject.keyword | Benign prostatic obstruction | spa |
dc.subject.keyword | Clinical protocol | spa |
dc.subject.keyword | Disease association | spa |
dc.subject.keyword | Disease severity | spa |
dc.subject.keyword | Drug effect | spa |
dc.subject.keyword | Human | spa |
dc.subject.keyword | International prostate symptom score | spa |
dc.subject.keyword | Lower urinary tract symptom | spa |
dc.subject.keyword | Outcome assessment | spa |
dc.subject.keyword | Priority journal | spa |
dc.subject.keyword | Prostate disease | spa |
dc.subject.keyword | Quality of life | spa |
dc.subject.keyword | Systematic review | spa |
dc.subject.keyword | Urine retention | spa |
dc.subject.keyword | Urogenital tract disease assessment | spa |
dc.title | 5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction | spa |
dc.type | article | eng |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | |
dc.type.spa | Artículo | spa |